Abstract
A standardized CO2 extract from Humulus lupulus L. (hop extract) was investigated for its selective COX-1/2 inhibitory properties.
An in vitro model of inflammation using lipopolysaccharide (LPS)-stimulated human peripheral
blood mononuclear cells (PBMC) was used as a model to investigate the effect of hop
extract on PGE2 production. COX-1/2 selective inhibition by the hop extract was investigated in a
COX-1 whole blood assay (WBA) and a COX-2 WBA. To evaluate the in vivo activity of hop extract, it was administered orally to C57BL/6 mice in which inflammation
of the right joint was induced by injecting zymosan intra-articularly. Ex vivo PGE2 production of LPS-stimulated blood cells was determined. Also, the effect of hop
extract on healthy and arthritic cartilage was investigated as well as effects on
inflammatory joint swelling. Hop extract inhibited PGE2 production by LPS-stimulated PBMC without compromising the metabolic activity of
these cells. Furthermore, hop extract showed a decline in PGE2 production in the COX-2 whole blood assay (WBA) with an IC50 of 20.4 μg/mL, while in the COX-1 WBA no inhibition of PGE2 production was observed. This indicates a COX-2 selective inhibition. The COX-1 inhibitor
SC-560 inhibited PGE2 production in the COX-1 WBA but not in the COX-2 WBA. At 2 μM, celecoxib inhibited
PGE2 production in the COX-2 WBA by 92 % and in the COX-1 WBA by 50 %. When hop extract
was administered orally to C57BL/6 mice in which joint inflammation was induced with
zymosan, PGE2 production in ex vivo LPS-stimulated whole blood was significantly decreased by 24 %, suggesting that hop
extract becomes bioavailable. Furthermore, oral administration of hop extract showed
no negative or positive effects on healthy cartilage proteoglycan synthesis, or on
zymosan-induced arthritic cartilage proteoglycan synthesis. However, no effect of
oral administration of 1.25 mg hop extract daily was observed on joint swelling. In
conclusion, this standardized CO2 extract of Humulus lupulus could be a useful agent for intervention strategies targeting inflammatory disorders
and/or inflammatory pain.
Key words
Humulus lupulus
- hops - PGE2
- cyclooxygenase - COX-1 - COX-2 - whole blood assay
References
- 1
Holtzman M J, Turk J, Shornick L P.
Identification of a pharmacologically distinct prostaglandin H synthase in cultured
epithelial cells.
J Biol Chem.
1992;
267
21 438-45
- 2
Hla T, Neilson K.
Human cyclooxygenase-2 cDNA.
Proc Natl Acad Sci USA.
1992;
89
7384-8
- 3
Chandrasekharan N V, Dai H, Roos K L, Evanson N K, Tomsik J, Elton T S. et al .
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic
drugs: cloning, structure, and expression.
Proc Natl Acad Sci USA.
2002;
99
13 926-31
- 4
Taniura S, Kamitani H, Watanabe T, Eling T E.
Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in
normal human astrocyte cells.
J Biol Chem.
2002;
277
16 823-30
- 5
Smith C J, Morrow J D, Roberts LJ 2 nd, Marnett L J.
Induction of prostaglandin endoperoxide synthase-1 (COX-1) in a human promonocytic
cell line by treatment with the differentiating agent TPA.
Adv Exp Med Biol.
1997;
400A
99-106
- 6
Doroudi R, Gan L M, Sjogren L S, Jern S.
Intraluminal pressure modulates eicosanoid enzyme expression in vascular endothelium
of intact human conduit vessels at physiological levels of shear stress.
J Hypertens.
2002;
20
63-70
- 7
Martel-Pelletier J, Pelletier J P, Fahmi H.
Cyclooxygenase-2 and prostaglandins in articular tissues.
Semin Arthritis Rheum.
2003;
33
155-67
- 8
Cryer B, Kimmey M B.
Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs.
Am J Med.
1998;
105
20S-30S
- 9
Vane J R.
The fight against rheumatism: from willow bark to COX-1 sparing drugs.
J Physiol Pharmacol.
2000;
51
573-86
- 10
Flower R J.
The development of COX2 inhibitors.
Nat Rev Drug Discov.
2003;
2
179-91
- 11 Duke J A, Wain K K. Medicinal plants of the world.
In: Computer index with more than 85,000 entries 3. 1981
- 12 Moerman D E. Geraniums for the Iroquois: a field guide to American Indian medicinal
plants. Michigan, Algonac; 1982
- 13
Yamamoto K, Wang J, Yamamoto S, Tobe H.
Suppression of cyclooxygenase-2 gene transcription by humulone.
Adv Exp Med Biol.
2002;
507
73-7
- 14
Yamamoto K, Wang J, Yamamoto S, Tobe H.
Suppression of cyclooxygenase-2 gene transcription by humulone of beer hop extract
studied with reference to glucocorticoid.
FEBS Lett.
2000;
465
103-6
- 15
Hougee S, Sanders A, Faber J, Graus Y MF, van den Berg W B, Garssen J. et al .
Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination
of monocytes/macrophages.
Biochem Pharmacol.
2005;
69
241-8
- 16
Warner T D, Giuliano F, Vojnovic I, Bukasa A, Mitchell J A, Vane J R.
Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are
associated with human gastrointestinal toxicity: a full in vitro analysis.
Proc Natl Acad Sci USA.
1999;
96
7563-8
- 17
Verschure P, van Marle J, Joosten L, van den Berg W.
Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse
articular cartilage during various phases of experimentally induced arthritis.
Ann Rheum Dis.
1995;
54
645-53
- 18
Dingle J T.
The effects of NSAID on the matrix of human articular cartilages.
Z Rheumatol.
1999;
58
125-9
- 19
de Vries B J, van den Berg W B, Vitters E, van de Putte L B.
Quantitation of glycosaminoglycan metabolism in anatomically intact articular cartilage
of the mouse patella: in vitro and in vivo studies with 35S-sulfate, 3H-glucosamine, and 3H-acetate.
Rheumatol Int.
1986;
6
273-81
- 20
Lemay M, Murray M A, Davies A, Roh-Schmidt H, Randolph R K.
In vitro and ex vivo cyclooxygenase inhibition by a hops extract.
Asia Pac J Clin Nutr.
2004;
13
S110
- 21
de Vries B J, van den Berg W B, Vitters E, van de Putte L B.
Effects of NSAIDs on the metabolism of sulphated glycosaminoglycans in healthy and
(post) arthritic murine articular cartilage.
Drugs.
1988;
35 Suppl 1
24-32
- 22
Hugenberg S T, Brandt K D, Cole C A.
Effect of sodium salicylate, aspirin, and ibuprofen on enzymes required by the chondrocyte
for synthesis of chondroitin sulfate.
J Rheumatol.
1993;
20
2128-33
- 23
Dingle J T.
Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAID and prostaglandins
in articular cartilage damage and repair.
J Rheumatol.
1991;
28 (Suppl)
30-7
- 24
Brandt K D.
Nonsteroidal anti-inflammatory drugs and articular cartilage.
J Rheumatol.
1987;
14 Spec No
132-3
- 25
Wang B, Yao Y Y, Chen M Z.
Effects of indomethacin on joint damage in rat and rabbit.
Zhongguo Yao Li Xue Bao.
1998;
19
70-3
- 26
El Hajjaji H, Marcelis A, Devogelaer J P, Manicourt D H.
Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans
in human osteoarthritic cartilage.
J Rheumatol.
2003;
30
2444-51
- 27
Mastbergen S C, Lafeber F P, Bijlsma J W.
Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage.
Rheumatology (Oxford).
2002;
41
801-8
- 28
Blot L, Marcelis A, Devogelaer J P, Manicourt D H.
Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans
and hyaluronan in osteoarthritic human cartilage.
Br J Pharmacol.
2000;
131
1413-21
- 29
Mastbergen S C, Bijlsma J W, Lafeber F P.
Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic
cartilage: a human in vitro study.
Osteoarthritis Cartilage.
2005;
13
519-26
- 30
Francischi J N, Chaves C T, Moura A C, Lima A S, Rocha O A, Ferreira-Alves D L. et
al .
Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw
model of inflammation.
Br J Pharmacol.
2002;
137
837-44
- 31
Feltenstein M W, Schuhly W, Warnick J E, Fischer N H, Sufka K J.
Anti-inflammatory and anti-hyperalgesic effects of sesquiterpene lactones from Magnolia and Bear’s foot.
Pharmacol Biochem Behav.
2004;
79
299-302
Sander Hougee
Numico Research
P.O. Box 7005
6700 CA Wageningen
The Netherlands
Email: Sander.Hougee@Numico-Research.nl